Glenmark Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

2,148.22

1,365.10

2,233.42

2,144.38

1,939.05

Operating profit

497.45

-184.27

470.85

485.00

217.67

Interest

83.39

73.60

58.19

61.93

58.86

Gross profit

1,200.33

0.94

458.88

472.42

391.78

EPS (Rs)

163.50

-0.72

10.72

9.63

-4.87

Other income

786.27

258.82

46.22

49.36

232.97

Stock adjustment

-2.12

-83.94

6.08

-23.08

-6.43

Raw material

685.45

701.17

807.03

796.76

777.09

Power and fuel

-

-

-

-

-

Employee expenses

337.75

379.56

383.00

334.47

306.12

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

629.70

552.57

566.46

551.25

644.60

Provisions made

-

-

-

-

-

Depreciation

52.40

51.16

49.85

48.75

46.73

Taxation

1,681.15

-55.09

87.01

120.39

-175.86

Net profit / loss

4,613.70

-20.41

302.35

271.66

-137.47

Extra ordinary item

5,146.91

-25.28

-19.67

-31.63

-658.37

Prior year adjustments

-

-

-

-

-

Equity capital

28.22

28.22

28.22

28.22

28.22

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

23.16

-13.50

21.08

22.62

11.23

GPM (%)

40.90

.06

20.13

21.54

18.04

NPM (%)

157.22

-1.26

13.26

12.38

-6.33